Licensing Services
Strategic guidance for in-licensing, out-licensing, and co-development of products, technologies, and intellectual property.
Our Licensing Services portfolio gives healthcare and life sciences organizations who wish to in-license, out-license, or co-develop products, technologies, and intellectual property strategic guidance and helps them carry out their objectives. We help pharmaceutical, biotechnology, medical device, and diagnostics firms uncover excellent licensing opportunities.
Key Highlights
We help our clients get strategic alignment and long-term value by using pipeline assessment, valuation modeling, competitive benchmarking, regulatory feasibility analysis, and risk assessments all together.
Our companies may extend their portfolios, acquire better access to new ideas, and become more competitive in international markets with structured licensing strategies.
We provide comprehensive partner scouting, term sheet formulation and negotiating support, and post-deal governance structures.
Our services include scientific and business due diligence to ensure licensing agreements deliver maximum value and strategic fit.
What's Included
- In-licensing and out-licensing strategy development
- Target/partner identification and scouting
- Asset screening and scientific evaluation
- Commercial due diligence and market potential analysis
- Financial valuation and deal modeling
- Intellectual property (IP) assessment and patent landscape review
- Regulatory feasibility and approval pathway evaluation
- Competitive benchmarking and portfolio fit analysis
- Term sheet development and deal structuring advisory